Calendar

Week of Dec 22, 2025

Dec 22, 2025device recall251d agoPhilips North America device recall (Cls II)

Patient Information Center iX; Software Version Number: 4.5.0 — Reason: A recent software (SW) patch modifies Mobile Event Notification filter settings without providing any indication to the user when upgrading the system. — Status: Ongoing

full page →fda device recalls ↗

Dec 22, 2025device recall251d agoMedline Industries, LP device recall (Cls I)

Reprocessed Biosense Webster SOUNDSTAR eco Diagnostic Ultrasound Catheters: Biosense Webster SOUNDSTAR eco Diagnostic Ultrasound Catheter Use on GE Systems 10439072RH; Biosense Webster SOUNDSTAR eco Diagnostic Ultrasound Catheter Use on Siemens Systems 10438577RH; Biosense Webster SOUNDSTAR eco Diagnostic Ultrasound Catheter, Use on Siemens Systems 10439011RH — Reason: These lots of reprocessed catheters may contain small particles of residual material. If affected devices are used, there is a risk of inflammatory response, systemic infection, or granulomatous reaction or thrombus reaction which may lead to cerebral or pulmonary embolism, or deep vein thrombosis. Expansion of recall Z-2610/2614-2025 — Status: Ongoing

full page →fda device recalls ↗

Dec 22, 2025device recall251d agoMedline Industries, LP device recall (Cls I)

Reprocessed Livewire Steerable Diagnostic Electrophysiology Catheters: Livewire Steerable Electrophysiology Catheter,10 Elec. 2-5-2mm 401582RH 401940RH; Livewire Steerable Electrophysiology Catheter,20 Elec. 2-10-2mm 401904RH; Livewire Steerable Electrophysiology Catheter,20 Elec. 2-5-2mm 401914RH; Livewire Steerable Electrophysiology Catheter,20 Elec. 2-8-2-60-2-8-2mm 401932RH; Livewire Steerable Electrophysiology Catheter,8 Elec. 2-2-2mm 401652RH; — Reason: These lots of reprocessed catheters may contain small particles of residual material. If affected devices are used, there is a risk of inflammatory response, systemic infection, or granulomatous reaction or thrombus reaction which may lead to cerebral or pulmonary embolism, or deep vein thrombosis. Expansion of recall Z-2610/2614-2025 — Status: Ongoing

full page →fda device recalls ↗

Dec 22, 2025device recall251d agoMedline Industries, LP device recall (Cls I)

Medline ReNewal Reprocessed ViewFlex Xtra ICE Catheters: ViewFlex Xtra ICE Catheter 9F x 90cm D087031RH 20197344019554¿ — Reason: These lots of reprocessed catheters may contain small particles of residual material. If affected devices are used, there is a risk of inflammatory response, systemic infection, or granulomatous reaction or thrombus reaction which may lead to cerebral or pulmonary embolism, or deep vein thrombosis. Expansion of recall Z-2610/2614-2025 — Status: Ongoing

full page →fda device recalls ↗

Dec 22, 2025grant251d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Integrative Predictors of Temporomandibular Degenerative Joint Disease

DE grant. $698,865. PI: Lucia H Cevidanes

full page →nih reporter ↗

Dec 22, 2025grant251d agoEMORY UNIVERSITY — Critical Care Training ProgramEmory University

GM grant. $3,000. PI: Craig M Coopersmith

full page →nih reporter ↗

Dec 22, 2025grant251d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Systems Genetics of Vascular Smooth Muscle PhenotypesUniversity of California Los Angeles

HL grant. $522,130. PI: Mete Civelek

full page →nih reporter ↗

Dec 22, 2025grant251d agoBOSTON UNIVERSITY MEDICAL CAMPUS — Integrating Multi-Omics to Uncover Shared Mechanisms Linking Physical Frailty...

AG grant. $49,438. PI: Jiachen Chen

full page →nih reporter ↗

Dec 23, 2025approval250d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL

full page →tramadol hydrochloride ER →fda approvals ↗

Dec 23, 2025approval250d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

full page →acetaminophen ER →fda approvals ↗

Dec 23, 2025approval250d agoTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

Week of Dec 22, 2025